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Monolayers of genetically modified proteins with an hexahistidine tag, (His)6, were obtained by using a 
Ni-NTA chelator synthesized on gold sputtered surfaces (via sulphide bonds), or on gold and graphite 
(via sililating agents) working electrodes of screen-printed devices. 
 
Two kinds of proteins were produced and purified for this study:  
a) a recombinant antibody, derived from the 'single chain Fv' ( scFv) format; 
b) a photosystem II (PSII) core complex isolated from the mutant strain CP43-H of the thermophilic 
cyanobacterium Synechococcus elongatus.  
 
An scFv, previously isolated from a synthetic ‘phage display’ library, was further engineered with an 
alkaline phosphatase activity genetically added between the carbossi-terminal of the scFvs and the 
(His)6 to allow direct measurement of immobilisation.  
 
Renewable specific binding of (His)6-proteins to gold and graphite surfaces and fast and sensitive 
electrochemical or optical detection of analytes were obtained. Additionally, “on chip” protein pre-
concentration was conveniently achieved for biosensing purposes, starting from crude unpurified 
extracts and avoiding protein purification steps. 
 






Biomolecules modified by genetic engineering represent a new and powerful approach for obtaining 
simpler artificial structures with new or improved properties (i.e. specificity, stability, sensitivity), useful for 
biosensors development. For instance, insertion of specific molecular tags can be used for oriented 
and reversible immobilization, preconcentration and purification, whereas, easier and sensitive 
analytical detection can be achieved by gene fusion with selected enzyme activities. Moreover, 
antibody derived fragments, like the single-chain Fv antibody fragment 'scFv' (Bird et al., 1988; Huston 
et al., 1988), offer the necessary sensitivity required for a sensing element and new desired specificities 
can be isolated from 'phage display' antibody libraries through the 'panning' procedure (Smith & Scott, 
1993; Winter et al. 1994).  
 
In this paper an original procedure for synthesizing functional groups (Ni-NTA) suitable for immobilisation 
of engineered (His)6-proteins on different sensor materials (gold, plastic, graphite, glass, quartz) are 
presented for gold and graphite surfaces and evaluated in terms of specific binding and activity of 
two kinds of different engineered proteins: an scFv-derived antibody and a PSII core complex. An scFv, 
already isolated from a synthetic phage display library (Desiderio et al., 2001) and characterized for 
binding activity (Villani et al., unpublished) was further engineered at the C-terminus, in order to add an 
alkaline phosphatase (AP) activity before the (His)6 tag, obtaining the fusion protein scFv-AP-(His)6. The 
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fusion protein was produced in the bacterial periplasm and used, rough or purified, for optimal 
(oriented) immobilization through the synthesized Ni-NTA chains on gold and graphite surfaces. No loss 
of functional properties (ability to bind the antigen) was observed, indicating suitability of recombinant 
antibodies as sensing molecular tools for biosensors. The engineered PSII core complex, containing an 
(His)6 tag, was also purified and immobilised by using the same Ni-NTA chelator on gold surfaces. The 
engineered PSII-(His)6 derived molecule represent a further step for the development of new PSII-based 
sensing devices (Koblizek et al, 1999; Koblizek et al,2001).  
 
 
MATERIALS AND METHODS 
 
 
a) Preparation of the scFv-AP-(His)6 
 
-Preparation of the scFv-AP-(His)6 espression plasmid: The scFv(CMV-G4) bacterial clone, expressing 
soluble scFv was picked out from selection against a plant virus (cucumber mosaic virus, CMV) 
(Desiderio et al.,2001). The scFv gene sequence was digested from the original pDN332 phagemid and 
subcloned as a SfiI-NotI fragment in the pDAP2 expression vector (CODON genetic system GmbH), for 
the production of a bifunctional protein, scFv-AP-(His)6, with both antigen binding activity as well as AP 
activity, and an (His)6 (Kerschbaumer et al., 1996).  
 
-Expression of the scFv-AP-(His)6 fusion protein: Competent TG1 E. coli cells were transformed with the 
ligation product and cultured at 37°C for 16h on 2xYT agar (1.5%) medium containing 100 µg/ml of 
ampicillin and 2% glucose (2xYT-AG). Single colonies were subjected to PCR screening. After a mini 
induction experiment (in order to assess the ability of the fusion protein to bind the antigen in ELISA and 
the presence of AP activity), a positive clone was picked and cultured overnight at 30°C for maxi-
induction. The culture was diluted to OD600=0.05 in 1L of 2xYT-AG and grown at 30°C with vigorous 
shaking (250rpm). At OD600 of about 0.8-0.9, the cells were collected by centrifugation and 
resuspended in 1L of 2xYT containing 100µg/ml ampicillin and 1mmol/L IPTG (isopropyl-1-thio-β-D-
galactopiranoside) to induce protein expression. The cells were then cultured for 16h at 30°C. After 
centrifugation at 3000g for 20min, the bacterial pellet was resuspended in ice-cold TES medium 
(0.2mol/L Tris-HCl pH 8.0, 0.5mmol/L EDTA, 0.5mol/L sucrose, 1ml TES for 100ml initial culture), containing 
protease inhibitors (Roche). After adding water-diluted TES (1:5, 1.5ml for 100ml initial culture), the cells 
were incubated on ice for 30min and then centrifuged at 4000g for 25min. The supernatant 
(Periplasmic Extract fraction 1, EP1) was collected. Pellets were resuspended in 15ml 5mmol/L MgSO4, 
containing protease inhibitors, and shaken for additional 10min before further extraction. The 
supernatant EP2 was collected after centrifugation at 20000g for 20min.  
 
Purification of the scFv-AP-(His)6 fusion protein: Fractions EP1 and EP2 were independently 
concentrated by ultrafiltration on a Diaflo YM10 membrane (Amicon) and subjected to immobilised-
metal affinity chromatography (IMAC) using Ni-NTA (QIAgen), following the procedure recommended 
by the manufacturer. Eluted fractions were collected, dialized against PBS and quantified by reading 
the absorbance at 280nm. Protein purity was checked by SDS-PAGE (12%w/v) followed by Coomassie 
staining. Approximately 360 µg of purified protein was obtained from 1L of bacterial culture. 
 
 
b) Purification of PSII-(His)6 core complex 
 
Thermophilic cyanobacterial Synechococcus elongatus 43H cells expressing psbC with an (His)6 
extension were used for purification of PSII-(His)6 core complexes (Sugiura et al. 1999).The eluate from a 
Ni2+-affinity column was diluted in 40mmol/L MES/NaOH (pH 6.5), 100mmol/L NaCl, 15mmol/L CaCl2, 
15mmol/L MgCl2, 0.03% DM and 10% glycerol for reducing amount of imidazole, and then they were 
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concentrated with a Centriprep-100 (Amicon, Inc., MA) to a chlorophyll concentration of 9.2mg/mL 
(imidazole content was finally 12.5mmol/L). 
 
 
c) Immobilisation procedures 
 
-Deposition of thin gold layers on glass and plastic surfaces: In all experiments, thin transparent layers of 
gold were deposited by commercial sputter coaters. The best deposition procedure on glass was 
achieved as follows: 1h washing of glass slides in cold ‘piranha’ solution (sulphuric acid/hydrogen 
peroxide 1:2), drying at 80oC directly before the deposition. The gold layers deposited in this way were 
stable during the chelator synthesis and resistant even to non-polar solutions (chloroform, 12h). In the 
case of plastic support, gold was sputtered on both sides of the small circles (o.d.=6mm) cut from a 
laser printer transparent foil. The conditions for deposition were the same as in the case of glass slides, 
but they were not washed or chemically treated before deposition. 
 
-Synthesis of the Ni-NTA chelator and Ni+2 assay: Two types of chelators were synthesized for (His)6-
protein immobilisation. The one with the long-arm spacer created by inserting lysine molecule into the 
chain and the other without spacer. Graphite thick films deposited by screen printing on PVC sheets 
were treated (1h at room temperature) with 10% 3-aminopropyltriethoxysilane (3-APTES) in PBS for 
obtaining -NH2 groups exposed out the surface. Glass or plastic slides with sputtered gold were treated 
with 20mmol/L cysteamine dissolved in ethanol for at least 12h and resulted in a self assembled 
monolayer (SAM) with the -NH2 groups exposed out the surface. These functional groups were used for 
further synthesis of both chelators. The synthesis followed the common scheme: a) 10% glutaraldehyde 
in PBS b) 5% lysine c)10% glutaraldehyde in PBS, d) 5% Nα-Nα-bis(carboxymethyl)-L-Lysine Hydrate, e) 
1% NiSO4; the chelator without spacer was obtained by omitting steps (b) and (c); each step of 
synthesis lasted 2h. At the end of each step samples were washed in PBS.  
Then, Ni was eluted from the samples with 25% HNO3 for determination by AdCSV (Adsorptive 
Cathodic Stripping Voltammetry), according to the DIN 38406E16 Standard Method for trace metals 
analysis. In a polarographic vessel 0.5mL of sample were added to 8mL of water, 0.25mL of DMG 
solution, 0.5mL of ammonium chloride buffer pH=9.5±0.2 and bubbled with nitrogen for 5min. Ni 
content determination was carried out with three standard additions.  
 
-Immobilisation of scFv-AP-(His)6 protein: The amount of fusion protein bound to the plastic and glass 
support was assayed after loading at 4°C in the dark for 1 or 16h. Then, the calibration curve of fusion 
enzyme activity was obtained and the maximum capacity of chelator groups determined. The 
saturating concentration of protein in the loading buffer was found to be 1ng/µL. AP activity 
immobilised on the samples was determined at 405nm using p-nithophenylphosphate as a substrate. 
Electrochemical AP activity measurement was performed with screen printed electrodes (Krejci 
Engineering, Ltd) in a flow µ-cell as described in fig.1. 
 
-Immobilisation of PSII-(His)6 core complex: The highest quantity of immobilised PSII-(His)6 core complex 
on the surface of plastic and glass substrates was obtained by incubation in MES buffer solution 
(pH=6.5) containing PSII-(His)6 equivalent to 300µgChl/mL at 4°C in complete darkness for 16h. 
Chlorophyll fluorescence measurements were done on a spectrofluorometer (TRIAX 180, Jobin Yvon–
Spex) at laboratory temperature. Fourier transform infrared (FTIR) spectra were also obtained (Perkin 






The two procedures for chelator synthesis were compared in terms of quantity of Ni-NTA groups and in 
terms of specific and non-specific binding capacity of (His)6-proteins. Only data on plastic are reported 
because results were comparable in all experiments. 
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Ni+2 determination by AdCSV on the substrates revealed high amount of NTA groups with no significant 
differences between the chelator with or without lysine spacer (tab.1). Moreover, surface density of 
the NTA groups was higher compared to commercial Ni-NTA treated µ−titre-plates: threefold on 
graphite printed on PVC, tenfold on sputtered gold (glass or plastic). 
 
 
Table 1: Ni+2 surface density (ng/cm2) on synthesized and commercial surfaces determined by AdCSV 
Substrate chemical treatment Ni+2 surface density (ng/cm2)+s.d. (n=3)* C.V. 
 blank 4.3+0.1 2,3% 
spacer 122+3.0 2.6% 
sputtered gold on plastic  
blank 4.4+0.2 4.5% 
 no spacer 114+2.0 1.7% 
printed graphite ink  on PVC no spacer 27 - 
commercial µ−titre-plates - 10 - 
DP-Voltammogram at the HMDE: deposition potential=-0.8V,deposition time=90 s, start potential=-0.80V, final potential=-0.45V, DP 
amplitude=-50mV. The Ni peak potential is at ñ0.97V vs Ag/AgCl. 
 
 
In order to perform direct measurements of immobilisation, an scFv fused to AP was used. Specific 
immobilisation of scFv-AP-(His)6 through the (His)6 was confirmed by the possibility of eluting the protein 
with 200mmol/L imidazole and assuming the residual AP activity as a measure of non-specific binding 




Table 2: AP activity of immobilised scFv-AP- (His)6 before and after washing with imidazole 
Substrate Treatments surface area OD405+s.d. (n=3) C.V. 
scFv loading with purified protein 0.6cm2 0.563+0.030 5.3% 
sputtered gold on plastic with spacer  
washing with 200mmol/L imidazole  0.6cm2 0.153+0.010 6.5% 
scFv loading with purified protein 0.6cm2 0.679+0.010 6.8% 
sputtered gold on plastic without spacer 
washing with 200mmol/L imidazole  0.6cm2 0.230+0.030 13.0% 
sputtered gold on plastic with spacer  0.6cm2 0.061+0.012 19.7% 
sputtered gold on plastic without spacer 0.6cm2 0.004+0.002 50.0% 
commercial Ni-NTA coated µ−titre-plates 
scFv loading with bacterial extracts 
(ìon chipî pre-concentration) 
1.0cm2 0.014+0.003 21.4% 
 
 
After immobilisation and elution with imidazole, the scFv-fusion protein retained binding activity toward 
the antigen as confirmed by ELISA on CMV-coated µ−titre-plates.  
 
The possibility of direct pre-concentration of (His)6-proteins on sensor surface (“on chip” pre-
concentration) using rough bacterial extracts was evaluated. “On chip” pre-concentration was 
obtained after 16h of substrate treatment and better results (lower non-specific binding) were 
obtained with the substrate with chelator having a lysine spacer (Tab.2) which showed an higher 
binding capacity (about fourfold) than commercial (His)6-proteins sorbing µ−titre-plates (even higher, 
sevenfold, if the unfavourable surface area ratio of about 0.6:1, tab.2, 3rd column, is taken into 
account). Milk (5%) BSA (5%) and cytochrome c (5%) solutions were used with the aim of blocking non-
specific binding of proteins, but, in all cases, specific binding was also reduced.  
 
AP activity of the scFv-fusion protein was electrochemically  determined after binding to a printed gold 
electrode with the chelator without spacer. The calibration curve of enzyme activity as well as washing 
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out the protein with 200mmol/L imidazole were determined, by using ascorbate-2-phosphate as a 
substrate for  AP (fig.1). “On chip” pre-concentration, starting from the crude bacterial extracts 
containing the engineered scFv fragment was also possible with screen printed gold electrodes (data 
not shown).  
 
The presence and activity of PSII-(His)6 was tested by photoreduction of 2,6-dichlorophenolindophenol 
(DCPIP, 20mmol/L) at 620 nm after illumination of the samples for 45min with white light at the 
laboratory temperature. In all cases, the decrease in absorption of oxidised form of DCPIP due to the 
activity of PSII-(His)6 was observed, no matter whether the samples with or without spacer were used. 
After washing of the PSII-(His)6 loaded samples with 200mmol/L imidazole, photoreduction of DCPIP 
was measured once again. In this way, results already obtained with scFv-AP protein were confirmed. 
A significant decrease of activity (nearly to zero) was observed. Contrary to the antibody fragment, 
the engineered PSII-(His)6 core complex was nearly completely washed out and non-specific binding 
was significantly lower. Experiments were well reproducible and PSII-(His)6 core complex was not 
denaturated during immobilisation since it did not lose oxygen evolving activity (tab.3). The amount of 
PSII-(His)6 bound to the substrate without the spacer was higher compared to the substrate with the 
lysine spacer.  
 
 
Table 3: PSII-(His)6 core complex activity measured by photoreduction of DCPIP before and after washing with imidazole 
Substrate Treatment OD620*+s.d. (n=3) 
PSII-(His)6 core omplex loading 0.032+0.013 
sputtered gold on plastic with spacer 
after washing with imidazole 200mmol/L 0.006+0.007 
PSII-(His)6 core omplex loading 0.047+0.006 
sputtered gold on plastic without spacer  
after washing with imidazole 200mmol/L 0.007+0.006 
∗absolute value of OD620 decrease with respect to the blank sample 
 
 
The presence of PSII-(His)6 was also confirmed by measuring fluorescence in the region between 600 
and 700nm. The sample (PSII-(His)6 on plastic or glass) was illuminated with blue light (400-530 nm) and 
fluorescence detected against the blank (plastic, glass with chelator without PSII-(His)6). In all cases, 
the typical fluorescence curve of the PSII-(His)6 core complex was observed (fig.2) with a maximum at 
about 685nm and a longer-wavelength (725nm), broad shoulder (the shape of curve was compared 
to the one obtained with the PSII-(His)6 core complex in solution). A decrease of fluorescence was 
observed after washing the sample with the imidazole solution. Good reproducibility and high signal 
reached in this experiment confirmed the applicability of this procedure for immobilisation of PSII and 
preparation of optical biosensing devices (for example using fiber optics).  
 
PSII-(His)6 immobilisation was observed with FTIR absorption in case of glass samples in reflectance 
mode. Sample was let to dry before measurement at laboratory temperature and difference spectra 
were recorded before and after PSII-(His)6 loading. Typical absorption bands (amid I and amid II 
bands) in the 1000-2000 cm-1 regions were obtained. 
 
Also amperometric detection of PSII-(His)6 activity with a screen printed gold electrode polarised at 
+600mV vs Ag/AgCl and in presence of duroquinone as artificial electron acceptor was achieved 





Higher Ni-NTA loading was obtained on both graphite and gold surfaces compared to commercial 
products. Similar results with both (His)6-proteins are a good proof of possible universal use of this 
 6 
procedure for sensing purposes; it can be applied to several technological materials by changing the 
first step of chemical treatment. Imidazole can be specifically used for washing out the sensing 
molecule, for renewing it or replacing the biomediator depending on the analysis requirements. Slight 
difference in non-specific binding and in lenght of the optimal chelator arm can be expected using 
different (His)6-proteins. Finally, “on chip” protein pre-concentration was conveniently achieved for 
biosensing purposes, starting from crude unpurified extracts and avoiding time consuming, and 
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Legends of figures 
 
Figure 1: Immobilised AP activity checked  electrochemically with a screen printed gold electrode at +400mV vs 
Ag/AgCl in a flow µ−cell. (1) and (3) Current increased with substrate (2mM ascorbate-2-phosphate)  and 
recovered the baseline as soon as the buffer was injected (2). At the end of the recording also quick removal of 
the (His)6-protein was observed when imidazole was used as feeding solution together with the substrate (4). 
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Figure 2: Fluorescence spectra of PSII-(His)6 core complex immobilised on plastic sheets by using Ni+2 chelator 
(40 scans in four independent repetitions). 
